Antisense oligonucleotides
A drug technology that interrupts protein synthesis at the genetic level, being developed to knock down Lp(a) to unmeasurable levels.
As defined in 328 - Health Longevity
Other definitions
Short synthetic strands of nucleic acid designed to bind RNA and modify how a gene is expressed or processed.
Dinakar Singh - A Father’s Call To Action - [Invest Like the Best, EP.428]
Where it comes up · 2
- 328 - Health Longevity1 claim
- Dinakar Singh - A Father’s Call To Action - [Invest Like the Best, EP.428]1 claim
Most important claims · 2 of 2Search all claims for “Antisense oligonucleotides” →
- Lp(a) is genetically determined and elevated in roughly 1 in 8 to 1 in 12 people, raising risk of both atherosclerosis and aortic stenosis; everyone should have it tested once, ideally in their 20s or 30s, and although no drug yet targets it (one is ~4 years away via antisense oligonucleotides), an elevated Lp(a) is a stronger reason to aggressively lower apoB and monitor the aortic valve.328 - Health Longevity
- The team pursued three shots on goal, antisense oligonucleotides at Cold Spring Harbor, small molecules screened with PTC Therapeutics, and gene therapy with AveXis, and all three became approved SMA drugs.Dinakar Singh - A Father’s Call To Action - [Invest Like the Best, EP.428]